Document is current
Any future updates will be listed below
-
Authors
Inamoto, Yoshihiro https://orcid.org/0000-0003-4881-0427
Ito, Ayumu
Nakashima, Toshihisa
Usui, Asako
Takeda, Wataru
Tanaka, Takashi
Kim, Sung-Won
Kitano, Shigehisa
Watanabe, Keisuke
Kusaba, Kana
Aruga, Yu
Ikeda, Chiaki
Kojima, Minoru
Maezawa, Naoki
Matsui, Hirotaka
Hashimoto, Hironobu
Ogawa, Chitose
Fukuda, Takahiro
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (22K08517)
National Cancer Research and Development Fund (2023-A-16)
- License Information
-
More Information
Article History
Received: 17 January 2025
Revised: 11 March 2025
Accepted: 11 March 2025
First Online: 25 March 2025
Declarations
:
: Y.I. and H.M. are lead reviewers of the International Journal of Hematology. Y.I. reports personal fees from Novartis, Janssen, and Meiji Seika Pharma outside the submitted work. K.W. is a stockholder and a board member as a co-founder of ARC Therapies Corp. Other authors declare no conflicts of interest.
